William Meury - Net Worth and Insider Trading
William Meury Net Worth
The estimated net worth of William Meury is at least $4 Million dollars as of 2024-11-05. William Meury is the EVP & Chief Commercial Officer of Allergan PLC and owns about 15,729 shares of Allergan PLC (AGN) stock worth over $3 Million. William Meury is also the Director of Syndax Pharmaceuticals Inc and owns about 48,000 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $904,800. Details can be seen in William Meury's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Meury has not made any transactions after 2023-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Meury
William Meury Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Meury owns 2 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , and Karuna Therapeutics Inc (KRTX) .
Click here to see the complete history of William Meury’s form 4 insider trades.
Insider Ownership Summary of William Meury
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2023-08-02 | director |
| KRTX | Karuna Therapeutics Inc | 2023-01-03 | director & President and CEO |
William Meury Latest Holdings Summary
William Meury currently owns a total of 2 stocks. Among these stocks, William Meury owns 15,729 shares of Allergan PLC (AGN) as of May 17, 2018, with a value of $3 Million and a weighting of 77.04%. William Meury also owns 48,000 shares of Syndax Pharmaceuticals Inc (SNDX) as of August 2, 2023, with a value of $904,800 and a weighting of 22.96%.
Latest Holdings of William Meury
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGN | Allergan PLC | 2018-05-17 | 15,729 | 193.02 | 3,036,012 |
| SNDX | Syndax Pharmaceuticals Inc | 2023-08-02 | 48,000 | 18.85 | 904,800 |
Holding Weightings of William Meury
William Meury Form 4 Trading Tracker
According to the SEC Form 4 filings, William Meury has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 24,425 shares on May 17, 2018, which brought William Meury around $4 Million.
According to the SEC Form 4 filings, William Meury has made a total of 1 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 83,000 shares on August 2, 2023, which brought William Meury around $2 Million.
Insider Trading History of William Meury
- 1
William Meury Trading Performance
William Meury Ownership Network
Ownership Network List of William Meury
Ownership Network Relation of William Meury
William Meury Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
William Meury is the director of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, William Meury made 1 insider transaction in Syndax Pharmaceuticals Inc (SNDX) with a net sale of 83,000. Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 211,420 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan ,
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,997 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 293,747 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
William Meury Mailing Address
Above is the net worth, insider trading, and ownership report for William Meury. You might contact William Meury via mailing address: C/o Forest Laboratories, Inc., 909 Third Avenue, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
